News
News Center
Two independent innovative medicines of Jiuhua Huayuan appear in the national "13th five year plan" scientific and technological innovation achievement exhibition
Release time:
2021-10-25 15:42
Source:
From October 21 to 27, the national "13th five year plan" scientific and technological innovation achievement exhibition with the theme of "innovation driven development towards a scientific and technological power" was held in the Beijing exhibition hall. This exhibition is divided into 12 exhibition areas, including major special projects and regional innovation. Jiuhua Huayuan Pharmaceutical Co., Ltd. has two independent innovative drugs, Bairui granules and Yuye Jinhua antipyretic tablets, appearing in the "major special" exhibition area. With the theme of "major new drug innovation special infectious disease prevention and control special", the "major special" exhibition area focuses on displaying major new drug innovation and infectious disease prevention and control scientific research achievements.
Since its establishment in 2004, Jiuhua Huayuan Pharmaceutical has adhered to technical cooperation with excellent scientific research institutions and universities at home and abroad, and carried out cooperation and exchange based on the principles of complementary advantages, mutual benefit and common development, so as to create a source of power for the rapid development of scientific and technological innovation. At present, Jiuhua Jiuhua Huayuan Pharmaceutical Co., Ltd. has listed a number of new drugs, and has also made breakthrough progress in the research of four new drugs of category 1 of traditional Chinese medicine, eight new drugs of Category 3 of traditional Chinese medicine, and two new drugs of category 2 of chemical medicine.
Yuye Jinhua Qingre tablet on display this time is a 6-class innovative traditional Chinese medicine for the treatment of pharyngitis. It takes Yuye Jinhua as the king drug, and is compatible with Andrographis paniculata, Stephania, Radix Scrophulariae and other traditional Chinese medicines. It is an improved and upgraded formula for Yuye Qinghuo tablet. It is a 6-class innovative traditional Chinese medicine. It has the effects of clearing heat, relieving exterior, nourishing yin and reducing fire, and promoting pharynx and detumescence.
Bairui granule is a major scientific and technological special achievement of "improtant new medcine". It is a star product in the field of upper respiratory tract infection, which uses the whole herb of thymus as medicine and has remarkable curative effect in the treatment of upper respiratory tract infection. Because Bairui granule is safe, efficient and widely used in clinical practice, Jiuhua Huayuan Pharmaceutical Co., Ltd. is currently carrying out secondary development of it. Because children have special reactivity and sensitivity to drugs, their pharmacokinetic and pharmacodynamic characteristics are quite different from those of adults. However, most drugs in China, including some approved drugs for children, are difficult to find child subjects, and there are generally insufficient clinical trial data for children, which is also one of the reasons for the frequent occurrence of adverse drug reactions in children. As a pure traditional Chinese medicine preparation, Bairui granule has obvious advantages in the treatment of children's respiratory diseases. In order to increase the dosage form of children and provide accurate guidance for children's medication, Bairui granule has carried out the III clinical trial for the treatment of children's acute upper respiratory tract infection and children's acute bronchitis, with a view to leading the expansion of Chinese patent medicine to the field of Pediatrics and providing a new choice for the clinical treatment of children's respiratory diseases.
Innovation drives development and science and technology leads the future. The world today is undergoing great changes that have not been seen in a century. The internal and external environment faced by the development of the pharmaceutical industry is undergoing profound and complex changes. China's development during the "fourteenth five year plan" period and beyond has put forward more urgent requirements for accelerating scientific and technological innovation. In recent years, Jiuhua Huayuan Pharmaceutical Co., Ltd. has also achieved phased development results through years of continuous persistence, business innovation, scientific and technological innovation and marketing innovation. It has developed into a leading enterprise in specialized subdivisions and a leading enterprise in natural medicine and plant medicine. We will continue to take advantage of the east wind of scientific and technological power and innovation and development, face people's life and health, and continue to march in the breadth and depth of life science and technology.
Related News
